{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:35:48Z","timestamp":1790793348541,"version":"4.1.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T00:00:00Z","timestamp":1285200000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00702-010-0482-8","type":"journal-article","created":{"date-parts":[[2010,9,22]],"date-time":"2010-09-22T12:42:33Z","timestamp":1285159353000},"page":"821-839","source":"Crossref","is-referenced-by-count":159,"title":["Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease"],"prefix":"10.1007","volume":"118","author":[{"given":"Isidre","family":"Ferrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Dalf\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,23]]},"reference":[{"key":"482_CR1","doi-asserted-by":"crossref","unstructured":"Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA, Schapira AHV (2010) Chaperone-mediated autophagy markers are abnormal in Parkinson\u2019s disease brain. Arch Neurol [Epub ahead of print]","DOI":"10.1001\/archneurol.2010.198"},{"key":"482_CR2","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.3233\/JAD-2004-6S602","volume":"6","author":"JK Andersen","year":"2004","unstructured":"Andersen JK (2004) Iron dysregulation and Parkinson\u2019s disease. J Alzheimers Dis 6:S47\u2013S52","journal-title":"J Alzheimers Dis"},{"key":"482_CR3","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson JP, Walker DE, Goldstein JM, Laat R, Banducci K, Caccavello RJ, Barbour R, Huang J, Kling K, Lee M, Diep L, Keim PS, Shen X, Chartaway T, Schlossmacher MG, Seubert P, Schenk D, Sinha S, Gai WP, Chilcote TJ (2006) Phosphorylation of Ser 129 is the dominant pathological modification of synuclein in familial and sporadic Lewy body disease. J Biol Chem 281:29739\u201329759","journal-title":"J Biol Chem"},{"key":"482_CR4","first-page":"25","volume":"12","author":"P Anglade","year":"1997","unstructured":"Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease. Histol Histopathol 12:25\u201331","journal-title":"Histol Histopathol"},{"key":"482_CR5","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH, Tomita T, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Aggregation of \u03b1-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol 152:879\u2013884","journal-title":"Am J Pathol"},{"key":"482_CR6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cbpa.2008.02.019","volume":"12","author":"KJ Barnham","year":"2008","unstructured":"Barnham KJ, Bush AI (2008) Metals in Alzheimer\u2019s and Parkinson\u2019s diseases. Curr Opin Chem Biol 12:222\u2013228","journal-title":"Curr Opin Chem Biol"},{"key":"482_CR7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG, Arizona Parkinson\u2019s Disease Consortium (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613\u2013634","journal-title":"Acta Neuropathol"},{"key":"482_CR8","doi-asserted-by":"crossref","first-page":"15454","DOI":"10.1073\/pnas.0813216106","volume":"106","author":"M Biagioli","year":"2009","unstructured":"Biagioli M, Pinto M, Cesselli D, Zaninello M, Lazarevic D, Roncaglia P, Simone R, Vlachouli C, Plessy C, Bertin N, Beltrami A, Kobayashi K, Gallo V, Santoro C, Ferrer I, Rivella S, Beltrami CA, Carninci P, Raviola E, Gustincich S (2009) Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells. Proc Natl Acad Sci 106:15454\u201315459","journal-title":"Proc Natl Acad Sci"},{"key":"482_CR10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","volume":"32","author":"A Bloch","year":"2006","unstructured":"Bloch A, Probst A, Bissing H, Adams H, Tolnay M (2006) Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 32:284\u2013295","journal-title":"Neuropathol Appl Neurobiol"},{"key":"482_CR139","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.expneurol.2008.04.001","volume":"212","author":"H Braak","year":"2008","unstructured":"Braak H, del Tredici K (2008) Cortico-basal ganglia-cortical circuitry in Parkinson\u2019s disease reconsidered. Exp Neurol 212:226\u2013229","journal-title":"Exp Neurol"},{"key":"482_CR11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3940(99)00208-6","volume":"265","author":"H Braak","year":"1999","unstructured":"Braak H, Sandmann-Keil D, Gai W, Braak E (1999) Extensive axonal Lewy neurites in Parkinson\u2019s disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci Lett 265:67\u201369","journal-title":"Neurosci Lett"},{"issue":"suppl 3","key":"482_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-002-1301-4","volume":"249","author":"H Braak","year":"2002","unstructured":"Braak H, del Tredici K, Bratzke H, Hamm-Clement J, Sandemann-Keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages). J Neurol 249(suppl 3):1\u20135","journal-title":"J Neurol"},{"key":"482_CR13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, del Tredici K, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"482_CR14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"key":"482_CR15","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","volume":"64","author":"H Braak","year":"2005","unstructured":"Braak H, R\u00fcb U, Jansen Steur EN, del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic state in Parkinson disease. Neurology 64:1404\u20131410","journal-title":"Neurology"},{"key":"482_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-211-45295-0_15","volume":"70","author":"H Braak","year":"2006","unstructured":"Braak H, Muller CM, R\u00fcb U, Ackermann H, Bratzke H, de Vos RA, del Tredici K (2006) Pathology associated with sporadic Parkinson\u2019s disease: where does it end? J Neural Transm Suppl 70:89\u201397","journal-title":"J Neural Transm Suppl"},{"key":"482_CR17","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1471-4159.2009.06538.x","volume":"112","author":"SP Buira","year":"2010","unstructured":"Buira SP, Dentesano G, Albasanz JL, Moreno J, Juv\u00e9s S, Mart\u00edn M, Ferrer I, Barrachina M (2010) Increased striatal ying yang-1 levels in Parkinson \u2018s disease: a potential negative regulator of adenosine A2a receptor expression levels. J Neurochem 112:1273\u20131285","journal-title":"J Neurochem"},{"key":"482_CR18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11910-005-0072-6","volume":"5","author":"KR Chaudhuri","year":"2005","unstructured":"Chaudhuri KR, Yates L, Mart\u00ednez-Mart\u00edn P (2005) The non-motor symptom complex of Parkinson\u2019s disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 5:275\u2013283","journal-title":"Curr Neurol Neurosci Rep"},{"key":"482_CR19","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/mds.21007","volume":"21","author":"O Chiba-Falek","year":"2006","unstructured":"Chiba-Falek O, Lopez GJ, Nussbaum RL (2006) Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov Disord 21:1703\u20131708","journal-title":"Mov Disord"},{"key":"482_CR20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbagen.2008.02.005","volume":"1780","author":"SJ Chinta","year":"2008","unstructured":"Chinta SJ, Andersen JK (2008) Redox imbalance in Parkinson\u2019s disease. Biochem Biophys Acta 1780:1362\u20131367","journal-title":"Biochem Biophys Acta"},{"key":"482_CR21","doi-asserted-by":"crossref","first-page":"13256","DOI":"10.1074\/jbc.M314124200","volume":"279","author":"J Choi","year":"2004","unstructured":"Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, Li L (2004) Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson\u2019s and Alzheimer\u2019s diseases. J Biol Chem 279:13256\u201313264","journal-title":"J Biol Chem"},{"key":"482_CR22","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1074\/jbc.M414327200","volume":"280","author":"J Choi","year":"2005","unstructured":"Choi J, Rees HD, Weintraub ST, Levey AI, Chin LS, Li L (2005) Oxidative modifications and aggregation of Cu, Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem 280:11648\u201311655","journal-title":"J Biol Chem"},{"key":"482_CR23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","volume":"35","author":"Y Chu","year":"2009","unstructured":"Chu Y, Dodiya H, Aebischer P, Olanow CW, Kordower JH (2009) Alterations in lysosomal and proteasomal markers in Parkinson\u2019s disease: relationship to alpha-synuclein inclusions. Neurobiol Dis 35:385\u2013398","journal-title":"Neurobiol Dis"},{"key":"482_CR24","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.1093891","volume":"304","author":"KK Chung","year":"2004","unstructured":"Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L, Dawson VL, Dawson TM (2004) S-Nitrosylation of parkin regulates ubiquitination and compromises Parkin\u2019s protective function. Science 304:1328\u20131331","journal-title":"Science"},{"key":"482_CR25","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305:1292\u20131295","journal-title":"Science"},{"key":"482_CR26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurobiolaging.2006.10.022","volume":"29","author":"E Dalf\u00f3","year":"2008","unstructured":"Dalf\u00f3 E, Ferrer I (2008) Early \u03b1-synuclein lipoxidation in neocortex in Lewy body diseases. Neurobiol Aging 29:408\u2013417","journal-title":"Neurobiol Aging"},{"key":"482_CR27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nbd.2004.01.001","volume":"16","author":"E Dalf\u00f3","year":"2004","unstructured":"Dalf\u00f3 E, Barrachina M, Rosa JL, Ambrosio S, Ferrer I (2004) Abnormal \u03b1-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease. Neurobiol Dis 16:92\u201397","journal-title":"Neurobiol Dis"},{"key":"482_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnen\/64.1.1","volume":"64","author":"E Dalf\u00f3","year":"2005","unstructured":"Dalf\u00f3 E, Portero-Ot\u00edn M, Ayala V, Mart\u00ednez A, Pamplona R, Ferrer I (2005) Evidence of oxidative stress in the neocortex in incidental Lewy body disease. J Neuropathol Exp Neurol 64:1\u201313","journal-title":"J Neuropathol Exp Neurol"},{"key":"482_CR29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0140-6736(92)93275-R","volume":"340","author":"SE Daniel","year":"1992","unstructured":"Daniel SE, Hawkes CH (1992) Preliminary diagnosis of Parkinson\u2019s disease by olfactory bulb pathology. Lancet 340:186","journal-title":"Lancet"},{"key":"482_CR30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici K, R\u00fcb U, De Vos RA, Bohl JR, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413\u2013426","journal-title":"J Neuropathol Exp Neurol"},{"key":"482_CR31","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archneur.65.8.1074","volume":"65","author":"A DelleDonne","year":"2008","unstructured":"DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uiti RJ, Ahlskog JE, Dickson DW (2008) Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 65:1074\u20131080","journal-title":"Arch Neurol"},{"key":"482_CR32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.410350107","volume":"35","author":"DT Dexter","year":"1994","unstructured":"Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Daniel SE, Lees AJ, Schapira AH (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 35:38\u201344","journal-title":"Ann Neurol"},{"key":"482_CR33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00019052-200108000-00001","volume":"14","author":"DW Dickson","year":"2001","unstructured":"Dickson DW (2001) Alpha-synuclein and the Lewy body disorders. Curr Opin Neurol 14:423\u2013432","journal-title":"Curr Opin Neurol"},{"key":"482_CR34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","volume":"115","author":"DW Dickson","year":"2008","unstructured":"Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson\u2019s disease. Acta Neuropathol 115:437\u2013444","journal-title":"Acta Neuropathol"},{"issue":"Suppl 1","key":"482_CR35","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1002\/mds.22637","volume":"25","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y (2010) Evidence in favor of Braak staging of Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S78\u2013S82","journal-title":"Mov Disord"},{"key":"482_CR36","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1073\/pnas.92.9.3717","volume":"93","author":"M Digicaylioglu","year":"1995","unstructured":"Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M (1995) Localization of specific erythropoietin binding sites in defined areas of the human brain. Proc Natl Acad Sci USA 93:3717\u20133720","journal-title":"Proc Natl Acad Sci USA"},{"key":"482_CR37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00702-006-0450-5","volume":"113","author":"KL Double","year":"2006","unstructured":"Double KL (2006) Functional effects of neuromelanin and synthetic melanin in model systems. J Neuarl Transm 113:751\u2013756","journal-title":"J Neuarl Transm"},{"key":"482_CR38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-211-45295-0_19","volume":"70","author":"KL Double","year":"2006","unstructured":"Double KL, Halliday GM (2006) New face of neuromelanin. J Neural Transm Suppl 70:119\u2013123","journal-title":"J Neural Transm Suppl"},{"key":"482_CR39","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0002-9440(10)64781-5","volume":"157","author":"JE Duda","year":"2000","unstructured":"Duda JE, Giasson BI, Chen Q, Gur TL, Hurtig HI, Stern MB, Gollomp SM, Ischiropoulos H, Lee VM, Trojanowski JQ (2000) Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol 157:1439\u20131445","journal-title":"Am J Pathol"},{"key":"482_CR40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-3-211-45295-0_47","volume":"70","author":"Wolters ECh","year":"2006","unstructured":"ECh Wolters, Braak H (2006) Parkinson\u2019s disease: pre-motor clinico-pathological correlations. J Neural Transm Suppl 70:309\u2013319","journal-title":"J Neural Transm Suppl"},{"key":"482_CR41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4161\/auto.5604","volume":"4","author":"S Engelender","year":"2008","unstructured":"Engelender S (2008) Ubiquitination of alpha synuynucelin and autophagy in Parkinson\u2019s disease. Autophagy 4:372\u2013374","journal-title":"Autophagy"},{"key":"482_CR42","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1471-4159.2005.03638.x","volume":"96","author":"M Fasano","year":"2006","unstructured":"Fasano M, Bergamasco B, Lopiano L (2006) Modifications of the iron-neuromelanin system in Parkinson\u2019s disease. J Neurochem 96:909\u2013916","journal-title":"J Neurochem"},{"key":"482_CR43","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/brain\/119.3.823","volume":"119","author":"A Fernandez","year":"1996","unstructured":"Fernandez A, de Ceballos ML, Rose S, Jenner P, Marsden CD (1996) Alterations in peptide levels in Parkinson\u2019s disease and incidental Lewy body disease. Brain 119:823\u2013830","journal-title":"Brain"},{"key":"482_CR44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2009.02.004","volume":"88","author":"I Ferrer","year":"2009","unstructured":"Ferrer I (2009a) Early involvement of the cerebral cortex in Parkinson\u2019s disease: convergence of multiple metabolic defects. Progr Neurobiol 88:89\u2013103","journal-title":"Progr Neurobiol"},{"key":"482_CR45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10863-009-9243-5","volume":"41","author":"I Ferrer","year":"2009","unstructured":"Ferrer I (2009b) Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer\u2019s disease. J Bioenerg Biomembr 41:425\u2013431","journal-title":"J Bioenerg Biomembr"},{"key":"482_CR46","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s007020100015","volume":"108","author":"I Ferrer","year":"2001","unstructured":"Ferrer I, Blanco R, Carmona M, Puig B, Barrachina M, G\u00f3mez C, Ambrosio S (2001) Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK\/ERK), stress-activated protein kinase\/c-Jun N-terminal kinase (SAPK\/JNK), and p38 kinase expression in Parkinson\u2019s disease and dementia with Lewy bodies. J Neural Transm 108:1383\u20131396","journal-title":"J Neural Transm"},{"key":"482_CR47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno LS (1996) Neuropathology of Parkinson\u2019s disease. J Neuropathol Exp Neurol 55:259\u2013272","journal-title":"J Neuropathol Exp Neurol"},{"key":"482_CR48","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/archneurol.2009.170","volume":"66","author":"R Frigerio","year":"2009","unstructured":"Frigerio R, Fujishiro H, Maraganore DM, Klos KJ, DelleDonne A, Heckman MG, Crook JE, Josephs KA, Parisi JE, Boeve BF, Dickson DW, Ahlskog JE (2009) Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. Arch Neurol 66:1114\u20131119","journal-title":"Arch Neurol"},{"key":"482_CR49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb841","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) \u03b1-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164","journal-title":"Nat Cell Biol"},{"key":"482_CR50","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/mds.21440","volume":"22","author":"K Fuxe","year":"2007","unstructured":"Fuxe K, Marcellino D, Genedani S, Agnati L (2007) Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson\u2019s disease. Mov Disord 22:1990\u20132017","journal-title":"Mov Disord"},{"key":"482_CR51","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2174\/187152709789824642","volume":"8","author":"M Garc\u00eda-Arencibia","year":"2009","unstructured":"Garc\u00eda-Arencibia M, Garc\u00eda C, Fern\u00e1ndez-Ruiz J (2009) Cannabinoids and Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 8:432\u2013439","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"482_CR52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-211-45295-0_21","volume":"70","author":"M Gerlach","year":"2006","unstructured":"Gerlach M, Double KL, Youdim MB, Riederer P (2006) Potential sources of increased iron in the substantia nigra of parkinsonian patients. J Neural Transm Suppl 70:133\u2013142","journal-title":"J Neural Transm Suppl"},{"key":"482_CR53","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","volume":"290","author":"BI Giasson","year":"2000","unstructured":"Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropuolos H, Trojanowski JQ, Lee VMY (2000) Oxidative damage linked to neurodegeneration by selective \u03b1-synuclein nitration in synucleinopathy lesions. Science 290:985\u2013989","journal-title":"Science"},{"key":"482_CR54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1515\/CCLM.2001.047","volume":"39","author":"M Goedert","year":"2001","unstructured":"Goedert M (2001) Parkinson\u2019s disease and other \u03b1-synucleinopathies. Clin Chem Lab Med 39:308\u2013312","journal-title":"Clin Chem Lab Med"},{"key":"482_CR55","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jnr.21904","volume":"87","author":"A G\u00f3mez","year":"2009","unstructured":"G\u00f3mez A, Ferrer I (2009) Increased oxidation of certain glycolysis and energy metabolism enzymes in the frontal cortex in Lewy body diseases. J Neurosci Res 87:1002\u20131013","journal-title":"J Neurosci Res"},{"key":"482_CR140","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/brain\/awh584","volume":"128","author":"GM Halliday","year":"2005","unstructured":"Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL (2005) Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Brain 128:2654\u20132664","journal-title":"Brain"},{"key":"482_CR141","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1750-3639.1999.tb00552.x","volume":"9","author":"M Hashimoto","year":"1999","unstructured":"Hashimoto M, Masliah E (1999) \u03b1-synuclein in Lewy body disease and Alzheimer\u2019s disease. Brain Pathol 9:707\u2013720","journal-title":"Brain Pathol"},{"key":"482_CR56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00415-008-0665-5","volume":"255","author":"B Herting","year":"2008","unstructured":"Herting B, Schulze S, Reichmann H, Haehner A, Hummel T (2008) A longitudinal study of olfactory function in patients with idiopathic Parkinson\u2019s disease. J Neurol 255:367\u2013370","journal-title":"J Neurol"},{"key":"482_CR57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-3-211-33328-0_21","volume":"71","author":"EC Hirsch","year":"2006","unstructured":"Hirsch EC (2006) Altered regulation of iron transport and storage in Parkinson\u2019s disease. J Neural Transm Suppl 71:201\u2013204","journal-title":"J Neural Transm Suppl"},{"key":"482_CR58","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2007.01.043","volume":"354","author":"JJ Hoozemans","year":"2007","unstructured":"Hoozemans JJ, van Haastert ES, Eikelenboom P, de Vos RA, Rozemuller JM, Scheper W (2007) Activation of the unfolded protein response in Parkinson\u2019s disease. Biochem Biophys Res Commun 354:707\u2013711","journal-title":"Biochem Biophys Res Commun"},{"key":"482_CR59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1469-7580.2007.00748.x","volume":"211","author":"PS Hubbard","year":"2007","unstructured":"Hubbard PS, Esiri MM, Reading M, McShane R, Nagy Z (2007) \u03b1-synuclein pathology in the olfactory pathways of dementia patients. J Anat 211:117\u2013124","journal-title":"J Anat"},{"key":"482_CR60","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","volume":"5","author":"A Iranzo","year":"2006","unstructured":"Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Marti MJ, Vallderiola F, Tolosa E (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5:572\u2013577","journal-title":"Lancet Neurol"},{"key":"482_CR61","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1016\/j.febslet.2007.08.067","volume":"581","author":"A Ishii","year":"2007","unstructured":"Ishii A, Nonaka T, Taniguchi S, Saito T, Arai T, Mann D, Iwatsubo T, Hisanaga S, Goedert M, Hasegawa M (2007) Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: implication for alpha-synucleinopathies. FEBS Lett 581:4711\u20134717","journal-title":"FEBS Lett"},{"key":"482_CR62","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1212\/WNL.52.6.1269","volume":"52","author":"K Iwanaga","year":"1999","unstructured":"Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, Satoh M, Tsujihara M, Takahashi H (1999) Lewy body-type degeneration in cardiac plexus in Parkinson\u2019s and incidental Lewy body disease. Neurology 52:1269\u20131271","journal-title":"Neurology"},{"key":"482_CR63","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","volume":"111","author":"KA Jellinger","year":"2004","unstructured":"Jellinger KA (2004) Lewy body-related synucleinopathy in the aged human brain. J Neural Transm 111:1219\u20131235","journal-title":"J Neural Transm"},{"key":"482_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","volume":"116","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol 116:1\u201316","journal-title":"Acta Neuropathol"},{"key":"482_CR65","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","volume":"1792","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009) A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 1792:730\u2013740","journal-title":"Biochim Biophys Acta"},{"key":"482_CR66","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000285518","volume":"7","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010) Prevalence and impact of cerebrovascular lesions in Alzheimer and Lewy body diseases. Neurodegener Dis 7:112\u2013115","journal-title":"Neurodegener Dis"},{"key":"482_CR67","first-page":"159","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"K Jellinger","year":"2003","unstructured":"Jellinger K, Mizuno Y (2003) Parkinson\u2019s disease. In: Dickson D (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropathol Press, Bassel, pp 159\u2013187"},{"key":"482_CR68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0404.1993.tb00013.x","volume":"146","author":"P Jenner","year":"1993","unstructured":"Jenner P (1993) Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson\u2019s disease. Acta Neurol Scand Suppl 146:6\u201313","journal-title":"Acta Neurol Scand Suppl"},{"key":"482_CR69","first-page":"24","volume":"13","author":"P Jenner","year":"1998","unstructured":"Jenner P (1998) Oxidative mechanisms in nigral cell death in Parkinson\u2019s disease. Mov Disord 13:24\u201334","journal-title":"Mov Disord"},{"key":"482_CR70","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/ana.410320714","volume":"32","author":"P Jenner","year":"1992","unstructured":"Jenner P, Dexter DT, Sian J, Schapira AH, Marsden CD (1992) Oxidative stress as a cause of nigral cell death in Parkinson\u2019s disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson\u2019s Disease Research Group. Ann Neurol 32:S82\u2013S87","journal-title":"Ann Neurol"},{"key":"482_CR71","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","volume":"26","author":"PM Keeney","year":"2006","unstructured":"Keeney PM, Xie J, Capaldi RA, Bennett JP (2006) Parkinson\u2019s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26:5256\u20135264","journal-title":"J Neurosci"},{"key":"482_CR72","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mds.10683","volume":"19","author":"AE Kingsbury","year":"2004","unstructured":"Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ (2004) Alteration in alpha-synuclein mRNA expression in Parkinson\u2019s disease. Mov Disord 19:162\u2013170","journal-title":"Mov Disord"},{"key":"482_CR73","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4161\/auto.5338","volume":"4","author":"DJ Klionsky","year":"2008","unstructured":"Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS et al (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4:151\u2013175","journal-title":"Autophagy"},{"key":"482_CR74","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.parkreldis.2006.10.002","volume":"13","author":"D Koziorowski","year":"2007","unstructured":"Koziorowski D, Friedman A, Arosio P, Santambrogio P, Dziewulska D (2007) ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson\u2019s disease and incidental Lewy body compared to control. Parkinsonism Relat Disord 13:214\u2013218","journal-title":"Parkinsonism Relat Disord"},{"key":"482_CR75","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","volume":"62","author":"E Kuusisto","year":"2003","unstructured":"Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241\u20131253","journal-title":"J Neuropathol Exp Neurol"},{"key":"482_CR76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1750-3639.2007.00048.x","volume":"17","author":"JB Leverenz","year":"2007","unstructured":"Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW, Jin J, Pan C, Shin J, Zhu D, Zhang J (2007) Proteomic identification of novel proteins in cortical Lewy bodies. Brain Pathol 17:139\u2013145","journal-title":"Brain Pathol"},{"key":"482_CR77","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","volume":"102","author":"W Li","year":"2005","unstructured":"Li W, West N, Colla E, Pletnikova O, Troncoso JC, Marsh L, Dawson TM, Jakala P, Hartmann T, Price DL, Lee MK (2005) Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson\u2019s disease-linked mutations. Proc Natl Acad Sci USA 102:2162\u20132167","journal-title":"Proc Natl Acad Sci USA"},{"key":"482_CR78","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.1074\/jbc.M109.074617","volume":"285","author":"SK Mak","year":"2010","unstructured":"Mak SK, McCormack AL, Manning-Bog AB, Cuervo AM, Di Monte DA (2010) Lysosomal degradation of \u03b1-synuclein in vivo. J Biol Chem 285:13621\u201313629","journal-title":"J Biol Chem"},{"key":"482_CR79","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/NEN.0b013e3181ac10a7","volume":"68","author":"WR Markesbery","year":"2009","unstructured":"Markesbery WR, Jicha GA, Liu H, Schmitt FA (2009) Lewy body pathology in normal elderly subjects. J Neuropathol Exp Neurol 68:816\u2013822","journal-title":"J Neuropathol Exp Neurol"},{"key":"482_CR80","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1750-3639.2009.00326.x","volume":"20","author":"A Mart\u00ednez","year":"2010","unstructured":"Mart\u00ednez A, Portero-Otin M, Pamplona R, Ferrer I (2010) Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol 20:281\u2013297","journal-title":"Brain Pathol"},{"key":"482_CR81","first-page":"777","volume":"118","author":"M Mart\u00ednez-Vicente","year":"2008","unstructured":"Mart\u00ednez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, Hodara R, Fredenburg R, Wu DC, Follenzi A, Dauer W, Przedborski S, Ischiropoulos H, Lansbury PT, Sulzer D, Cuervo AM (2008) Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 118:777\u2013788","journal-title":"J Clin Invest"},{"key":"482_CR82","doi-asserted-by":"crossref","first-page":"19488","DOI":"10.1016\/S0021-9258(17)32195-6","volume":"269","author":"S Matsuda","year":"1994","unstructured":"Matsuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R (1994) A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269:19488\u201319493","journal-title":"J Biol Chem"},{"key":"482_CR83","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000235247","volume":"28","author":"A McKinlay","year":"2009","unstructured":"McKinlay A, Grace RC, Dalrymple-Alford JC, Roger D (2009) Cognitive characteristics associated with mild cognitive impairment in Parkinson\u2019s disease. Dement Geriatr Cogn Disord 28:121\u2013129","journal-title":"Dement Geriatr Cogn Disord"},{"key":"482_CR84","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","volume":"163","author":"Y Mizuno","year":"1989","unstructured":"Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson\u2019s disease. Biochem Biophys Res Commun 163:1450\u20131455","journal-title":"Biochem Biophys Res Commun"},{"key":"482_CR85","unstructured":"Muntan\u00e9 G, Ferrer I, Mart\u00ednez-Vicente M \u03b1-Synuclein phosphorylation and lysosomal-mediated \u03b1-synuclein truncation are normal events in the adult human brain (in preparation)"},{"key":"482_CR86","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuroscience.2008.01.030","volume":"152","author":"G Muntan\u00e9","year":"2008","unstructured":"Muntan\u00e9 G, Dalf\u00f3 E, Martinez A, Ferrer I (2008) Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer\u2019s disease, and in Parkinson\u2019s disease and related \u03b1-synucleinopathies. Neuroscience 152:913\u2013923","journal-title":"Neuroscience"},{"key":"482_CR87","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1021\/bi027363r","volume":"42","author":"IV Murray","year":"2003","unstructured":"Murray IV, Giasson BI, Quinn SM, Koppaka V, Axelsen PH, Ischiropoulos H, Trojanowski JQ, Lee VM (2003) Role of alpha-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry 42:8530\u20138540","journal-title":"Biochemistry"},{"key":"482_CR88","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2004.03.029","volume":"1012","author":"K Nakaso","year":"2004","unstructured":"Nakaso K, Yoshimoto Y, Nakano T, Takeshima T, Fukuhara Y, Yasui K, Araga S, Yanagawa T, Ishii T, Nakashima K (2004) Transcriptional activation of p62\/A170\/ZIP during the formation of the aggregates: possible mechanisms and the role in Lewy body formation in Parkinson\u2019s disease. Brain Res 1012:42\u201351","journal-title":"Brain Res"},{"key":"482_CR89","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2982.2008.01162.x","volume":"20","author":"G Natale","year":"2008","unstructured":"Natale G, Pasquali L, Riuggieri S, Paparelli A, Fornai F (2008) Parkinson\u2019s disease and the gut: a well known clinical association in need of an effective cure and explanation. Neurogastroenterol Motil 20:741\u2013749","journal-title":"Neurogastroenterol Motil"},{"key":"482_CR90","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.freeradbiomed.2009.03.007","volume":"46","author":"A Navarro","year":"2009","unstructured":"Navarro A, Boveris A, B\u00e1ndez MJ, S\u00e1nchez-Pino MJ, G\u00f3mez C, Muntan\u00e9 G, Ferrer I (2009) Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies. Free Radic Biol Med 46:1574\u20131580","journal-title":"Free Radic Biol Med"},{"key":"482_CR91","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","volume":"68","author":"AE Oakley","year":"2007","unstructured":"Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, Morris CM (2007) Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 68:1820\u20131825","journal-title":"Neurology"},{"key":"482_CR92","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/mds.21013","volume":"21","author":"CW Olanow","year":"2006","unstructured":"Olanow CW, McNaught KS (2006) Ubiquitin-proteasome system and Parkinson\u2019s disease. Mov Disord 21:1806\u20131823","journal-title":"Mov Disord"},{"key":"482_CR93","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11064-007-9482-y","volume":"33","author":"IG Onyango","year":"2008","unstructured":"Onyango IG (2008) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Neurochem Res 33:589\u2013597","journal-title":"Neurochem Res"},{"key":"482_CR94","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/brain\/awm318","volume":"131","author":"T Pan","year":"2008","unstructured":"Pan T, Kondo S, Le W, Jankovic J (2008) The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson\u2019s disease. Brain 131:1969\u20131978","journal-title":"Brain"},{"key":"482_CR95","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","volume":"26","author":"WD Parker","year":"1989","unstructured":"Parker WD, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson\u2019s disease. Ann Neurol 26:719\u2013723","journal-title":"Ann Neurol"},{"key":"482_CR96","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.20321","volume":"57","author":"L Parkkinen","year":"2005","unstructured":"Parkkinen L, Kauppinen T, Pirttil\u00e4 T, Autere JM, Alafuzoff I (2005) \u03b1-Synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 57:82\u201391","journal-title":"Ann Neurol"},{"key":"482_CR97","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","volume":"115","author":"L Parkkinen","year":"2008","unstructured":"Parkkinen L, Pirttil\u00e4 T, Alafuzoff I (2008) Applicability of current staging\/categorization of \u03b1-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399\u2013407","journal-title":"Acta Neuropathol"},{"key":"482_CR98","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mds.870100309","volume":"10","author":"RK Pearce","year":"1995","unstructured":"Pearce RK, Hawkes CH, Daniel SE (1995) The anterior olfactory nucleus in Parkinson\u2019s disease. Mov Disord 10:283\u2013287","journal-title":"Mov Disord"},{"key":"482_CR99","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/jnnp.2008.170043","volume":"80","author":"KF Pedersen","year":"2009","unstructured":"Pedersen KF, Alves G, Aarsland D, Larsen JP (2009) Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study. J Neurol Neurosurg Psychiatry 80:1279\u20131782","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"482_CR100","doi-asserted-by":"crossref","first-page":"S374","DOI":"10.1002\/mds.21681","volume":"17","author":"W Poewe","year":"2007","unstructured":"Poewe W (2007) Dysautonomia and cognitive dysfunction in Parkinson\u2019s disease. Mov Disord Suppl 17:S374\u2013S378","journal-title":"Mov Disord Suppl"},{"issue":"Suppl 1","key":"482_CR101","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","volume":"15","author":"W Poewe","year":"2008","unstructured":"Poewe W (2008) Non-motor symptoms in Parkinson\u2019s disease. Eur J Neurol 15(Suppl 1):14\u201320","journal-title":"Eur J Neurol"},{"key":"482_CR102","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1212\/01.wnl.0000203648.80727.5b","volume":"66","author":"RB Postuma","year":"2006","unstructured":"Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J (2006) Potential early markers of Parkinson disease in idiopathic REM sleep behavioral disorder. Neurology 66:845\u2013851","journal-title":"Neurology"},{"key":"482_CR103","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/cne.22062","volume":"515","author":"F Richter","year":"2009","unstructured":"Richter F, Meurers BH, Zhu C, Medvedeva VP (2009) Neurons express haemoglobin \u03b1- and \u03b2-chains in rat and human brains. J Comp Neurol 515:538\u2013547","journal-title":"J Comp Neurol"},{"key":"482_CR104","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-8993(01)02772-X","volume":"914","author":"E Rockenstein","year":"2001","unstructured":"Rockenstein E, Hansen LA, Mallory M, Trojanowski JQ, Galasko D, Masliah E (2001) Altered expression of the synuclein family mRNA in Lewy body and Alzheimer\u2019s disease. Brain Res 914:48\u201356","journal-title":"Brain Res"},{"key":"482_CR105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.21291","volume":"63","author":"GW Ross","year":"2008","unstructured":"Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR (2008) Association of olfactory dysfunction with risk for future Parkinson\u2019s disease. Ann Neurol 63:167\u2013173","journal-title":"Ann Neurol"},{"key":"482_CR106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2007.08.027","volume":"266","author":"MY Ryu","year":"2008","unstructured":"Ryu MY, Kim DW, Arima K, Mouradian MM, Kim SU, Lee G (2008) Localization of CKII beta subunits in Lewy bodies of Parkinson\u2019s disease. J Neurol Sci 266:9\u201312","journal-title":"J Neurol Sci"},{"key":"482_CR107","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnen\/63.7.742","volume":"63","author":"Y Saito","year":"2004","unstructured":"Saito Y, Ruberu NN, Sawabe M, Arai T, Kazama H, Hosoi T, Yamanouchi H, Murayama S (2004) Lewy body-related \u03b1-synucleinopathy in aging. J Neuropathol Exp Neurol 63:742\u2013749","journal-title":"J Neuropathol Exp Neurol"},{"key":"482_CR108","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-211-33328-0_22","volume":"71","author":"J Salazar","year":"2006","unstructured":"Salazar J, Mena N, N\u00fa\u00f1ez MT (2006) Iron dyshomeostasis in Parkinson\u2019s disease. J Neural Transm Suppl 71:205\u2013213","journal-title":"J Neural Transm Suppl"},{"key":"482_CR109","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","volume":"7","author":"AH Schapira","year":"2008","unstructured":"Schapira AH (2008) Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease. Lancet Neurol 7:97\u2013109","journal-title":"Lancet Neurol"},{"key":"482_CR110","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","volume":"103","author":"CW Schults","year":"2006","unstructured":"Schults CW (2006) Lewy bodies. Proc Nat Acad Sci USA 103:1661\u20131668","journal-title":"Proc Nat Acad Sci USA"},{"key":"482_CR111","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00702-007-0789-2","volume":"114","author":"M Shamoto-Nagai","year":"2007","unstructured":"Shamoto-Nagai M, Maruyama W, Hashizume Y, Yoshida M, Osawa T, Riederer P, Naoi M (2007) In parkinsonian substantia nigra, \u03b1-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of the proteasome activity. J Neural Transm 114:1559\u20131567","journal-title":"J Neural Transm"},{"issue":"Suppl 2","key":"482_CR112","first-page":"S139","volume":"64","author":"A Siderowf","year":"2008","unstructured":"Siderowf A, Stern MB (2008) Premotor Parkinson\u2019s disease: clinical features, detection, and prospects for treatment. Ann Neurol 64(Suppl 2):S139\u2013S147","journal-title":"Ann Neurol"},{"key":"482_CR113","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1531-8249(200002)47:2<201::AID-ANA10>3.0.CO;2-F","volume":"47","author":"SM Solano","year":"2000","unstructured":"Solano SM, Miller DW, Augood SJ, Young AB, Penney JB Jr (2000) Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson\u2019s disease. Ann Neurol 47:201\u2013210","journal-title":"Ann Neurol"},{"key":"482_CR114","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt M, Lee VM, Trojanowski JQ, Kaques R, Goedert M (1997) \u03b1-Synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"482_CR115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1586\/epr.09.91","volume":"7","author":"G Srivastava","year":"2010","unstructured":"Srivastava G, Singh K, Tiwari MN, Singh MP (2010) Proteomics in Parkinson\u2019s disease: current trends, translational snags and future possibilities. Expert Rev Proteomics 7:127\u2013139","journal-title":"Expert Rev Proteomics"},{"key":"482_CR116","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1523\/JNEUROSCI.21-24-09549.2001","volume":"21","author":"L Stefanis","year":"2001","unstructured":"Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA (2001) Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 21:9549\u20139560","journal-title":"J Neurosci"},{"key":"482_CR117","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/brain\/awh322","volume":"128","author":"K Stiasny-Kolster","year":"2005","unstructured":"Stiasny-Kolster K, Doerr Y, M\u00f6ller JC, H\u00f6ffken H, Behr TM, Oertel WH, Mayer G (2005) Combination of idiopathic REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128:126\u2013137","journal-title":"Brain"},{"key":"482_CR118","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1523\/JNEUROSCI.4188-09.2010","volume":"30","author":"CC Tang","year":"2010","unstructured":"Tang CC, Poston KL, Dhawan V, Eidelberg D (2010) Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson\u2019s disease. J Neurosci 30:1049\u20131056","journal-title":"J Neurosci"},{"key":"482_CR119","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.parkreldis.2007.06.007","volume":"13","author":"E Tolosa","year":"2007","unstructured":"Tolosa E, Compta Y, Gaig C (2007) The premotor phase of Parkinson\u2019s disease. Parkinsonism Rel Disord 13:S2\u2013S7","journal-title":"Parkinsonism Rel Disord"},{"key":"482_CR120","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00702-006-0452-3","volume":"113","author":"F Tribl","year":"2006","unstructured":"Tribl F, Marcus K, Meyer HE, Bringmann G, Gerlach M, Riederer P (2006) Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle. J Neural Transm 113:741\u2013749","journal-title":"J Neural Transm"},{"key":"482_CR121","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1074\/mcp.M900006-MCP200","volume":"8","author":"F Tribl","year":"2009","unstructured":"Tribl F, Asan E, Arzberger T, Tatschner T, Langenfeld E, Meyer HE, Bringmann G, Riederer P, Gerlach M, Marcus K (2009) Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach. Mol Cell Proteomics 8:1832\u20131838","journal-title":"Mol Cell Proteomics"},{"key":"482_CR122","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1096\/fj.09-141044","volume":"24","author":"K Varani","year":"2010","unstructured":"Varani K, Vincenzi F, Tosi A, Gessi S, Casetta I, Granieri G, Fazio P, Leung E, MacLennan S, Granieri E, Borea PA (2010) A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson\u2019s disease. FASEB J 24:587\u2013598","journal-title":"FASEB J"},{"key":"482_CR123","doi-asserted-by":"crossref","first-page":"23542","DOI":"10.1074\/jbc.M801992200","volume":"283","author":"T Vogiatzi","year":"2008","unstructured":"Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L (2008) Wild type \u03b1-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 283:23542\u201323556","journal-title":"J Biol Chem"},{"key":"482_CR124","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","volume":"249","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H (1997) NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson\u2019s disease. Neurosci Lett 249:180\u2013182","journal-title":"Neurosci Lett"},{"key":"482_CR125","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","volume":"27","author":"K Wakabayashi","year":"2007","unstructured":"Wakabayashi K, Tanji K, Mori F, Takahashi H (2007) The Lewy body in Parkinson\u2019s disease: molecules implicated in the formation and degradation of \u03b1-synuclein aggregates. Neuropathology 27:494\u2013506","journal-title":"Neuropathology"},{"key":"482_CR126","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/ars.2006.1524","volume":"9","author":"HQ Wang","year":"2007","unstructured":"Wang HQ, Takahashi R (2007) Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson\u2019s disease. Antioxid Redox Signal 9:553\u2013561","journal-title":"Antioxid Redox Signal"},{"key":"482_CR127","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12264-008-1214-z","volume":"24","author":"R Wang","year":"2008","unstructured":"Wang R, Qing H, Liu XQ, Zheng XL, Deng YL (2008) Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells. Neurosci Bull 24:125\u2013132","journal-title":"Neurosci Bull"},{"key":"482_CR128","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/NEN.0b013e3186fc995","volume":"67","author":"EA Waxman","year":"2008","unstructured":"Waxman EA, Giasson BI (2008) Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. J Neuropathol Exp Neurol 67:402\u2013416","journal-title":"J Neuropathol Exp Neurol"},{"key":"482_CR129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1212\/01.wnl.0000266626.64913.0f","volume":"69","author":"D Weisman","year":"2007","unstructured":"Weisman D, Cho M, Taylor C, Adame A, Thal LJ, Hansen LA (2007) In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology 69:356\u2013359","journal-title":"Neurology"},{"key":"482_CR130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0169-328X(01)00150-4","volume":"92","author":"K Wirdefeldt","year":"2001","unstructured":"Wirdefeldt K, Bogdanovic N, Westerberg L, Payami H, Schalling M, Murdoch G (2001) Expression of alpha-synuclein in the human brain: relation to Lewy body disease. Brain Res Mol Brain Res 92:58\u201365","journal-title":"Brain Res Mol Brain Res"},{"key":"482_CR131","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.parkreldis.2010.02.007","volume":"16","author":"A Wypijewska","year":"2010","unstructured":"Wypijewska A, Galazka-Friedman J, Bauminger ER, Wszolek ZK, Schweitzer KJ, Dickson DW, Jaklewicz A, Elbaum D, Friedman A (2010) Iron and reactive oxygen species activity in parkinsonian substantia nigra. Parkinsonism Relat Disord 16:329\u2013333","journal-title":"Parkinsonism Relat Disord"},{"key":"482_CR132","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.2741\/2973","volume":"13","author":"Q Xia","year":"2008","unstructured":"Xia Q, Liao L, Cheng D, Duong DM, Gearing M, Lah JJ, Levey AI, Peng J (2008) Proteomic identification of novel proteins associated with Lewy bodies. Front Biosci 13:3850\u20133856","journal-title":"Front Biosci"},{"key":"482_CR133","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4161\/auto.6685","volume":"4","author":"M Xilouri","year":"2008","unstructured":"Xilouri M, Vogiatzi T, Vekrellis K, Stefanis L (2008) alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson\u2019s disease pathogenesis. Autophagy 4:917\u2013919","journal-title":"Autophagy"},{"key":"482_CR134","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF03033574","volume":"14","author":"MB Youdim","year":"2008","unstructured":"Youdim MB (2008) Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus. Neurotox Res 14:45\u201356","journal-title":"Neurotox Res"},{"issue":"Suppl 2","key":"482_CR135","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/WNL.67.7_suppl_2.S8","volume":"67","author":"L Zecca","year":"2006","unstructured":"Zecca L, Lucca FA, Albertini A, Rizzio E, Fariello RG (2006) A proposed dual role of neuromelanin in the pathogenesis of Parkinson disease. Neurology 67(Suppl 2):S8\u2013S11","journal-title":"Neurology"},{"key":"482_CR136","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1471-4159.2008.05541.x","volume":"106","author":"L Zecca","year":"2008","unstructured":"Zecca L, Casella L, Albertini A, Bellei C, Zucca FA, Engelen M, Zadlo A, Szewczyk G, Zareba M, Sarna T (2008) Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson\u2019s disease. J Neurochem 106:1866\u20131875","journal-title":"J Neurochem"},{"key":"482_CR137","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopha.2008.01.017","volume":"62","author":"GD Zeevalk","year":"2008","unstructured":"Zeevalk GD, Razmpour R, Bernard LP (2008) Glutathione and Parkinson\u2019s disease: is this the elephant in the room? Biomed Pharmacother 62:236\u2013249","journal-title":"Biomed Pharmacother"},{"key":"482_CR138","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.parkreldis.2006.12.014","volume":"13","author":"T Ziemssen","year":"2007","unstructured":"Ziemssen T, Reichmann H (2007) Non-motor dysfunction in Parkinson\u2019s disease. Parkinsonism Rel Disord 13:323\u2013332","journal-title":"Parkinsonism Rel Disord"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-010-0482-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-010-0482-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-010-0482-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T17:45:45Z","timestamp":1711820745000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-010-0482-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,23]]},"references-count":140,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1007\/s00702-010-0482-8","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,23]]}}}